S100A2 and ovarian endometrioid adenocarcinoma: In endometrioid ovarian cancer, higher mRNA expression of S100A12 (HR = 0.1, 95%CI: 0.01–0.89, P = 0.011), S100A13 (HR = 0.16, 95%CI: 0.03–0.97, P = 0.022) and S100G (HR = 0.1, 95%CI: 0.01–0.86, P = 0.0092) were associated with better OS, while S100A2 (HR = 4.9, 95%CI: 0.82–29.32, P = 0.054) and S100A10(HR =1,691,454,124.4, 95%CI: (0-Inf), P = 0.022) predicted worse survival (Fig. 2).